We describe the case of an immunocompromised patient, positive for influenza A virus (H3N2), in whom the neuraminidase R292K mutation was transiently detected during oseltamivir treatment. The R292K mutation was identified by direct testing in 3 of 11 respiratory specimens collected throughout the patient's illness but in none of the cultures from those specimens.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365243 | PMC |
http://dx.doi.org/10.1128/JCM.02845-14 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!